Sana Biotechnology (SANA) Assets Average (2021 - 2026)

Sana Biotechnology's Assets Average history runs 6 years deep, the most recent figure standing at $395.2 million for Q1 2026.

• In Q1 2026, Assets Average fell 16.48% year-over-year to $395.2 million; the TTM figure through Mar 2026 stood at $395.2 million (down 16.48% YoY), while the FY2025 annual figure was $459.0 million, down 13.92% from the prior year.
• Assets Average came in at $395.2 million for Q1 2026 at Sana Biotechnology, down from $426.2 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.1 billion in Q1 2022 to a low of $395.2 million in Q1 2026.
• A 5-year average of $656.6 million and a median of $623.3 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average grew 6.99% in 2022 and sank 37.92% in 2025, its largest moves.
• Sana Biotechnology's Assets Average stood at $860.4 million in 2022, then sank by 30.46% to $598.4 million in 2023, then decreased by 11.39% to $530.2 million in 2024, then declined by 19.62% to $426.2 million in 2025, then fell by 7.26% to $395.2 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $395.2 million, $426.2 million, and $398.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison